Literature DB >> 19415010

Some clinical findings at presentation can predict high-risk pathology features in unilateral retinoblastoma.

Guillermo L Chantada1, Andrea Gonzalez, Adriana Fandino, Maria T G de Davila, Graciela Demirdjian, Marcelo Scopinaro, David Abramson.   

Abstract

AIMS: To identify clinical features at presentation to help in detecting patients with retinoblastoma and pathology risk factors (PRFs) preoperatively, and therefore selecting a high-risk population that could benefit from preoperative treatment.
METHODS: A retrospective analysis of a prospectively filled form of 182 consecutive patients with unilateral retinoblastoma treated with initial enucleation from 1988 to 2006. Univariate and multivariate analyses were carried out. Major choroidal invasion and postlaminar optic nerve and scleral extension were considered PRFs. Within this subgroup, a higher-risk cohort (microscopical residual disease caused by trans-scleral invasion or invasion to the resection margin of the optic nerve) was analyzed separately.
RESULTS: One hundred sixty-four patients had completely resected and 18 had microscopical residual disease. Seventy three had at least 1 PRF (massive invasion to the choroid in 25, to the postlaminar optic nerve in 41, intrascleral in 10, to the resection margin of the optic nerve in 12, and trans-scleral in 6). Seventy-one patients had glaucoma and 19 had buphthalmia. Intraocular pressure, glaucoma, and buphthalmia correlated significantly with the occurrence of both PRF and microscopical residual disease in multivariate analysis. Buphthalmia was the most specific factor but the sensitivity was lower. Glaucoma and buphthalmia had a high negative predictive value.
CONCLUSIONS: Patients presenting with glaucoma and/or buphthalmia have a significantly higher risk for the occurrence of PRF, including those resulting in microscopically residual disease.

Entities:  

Mesh:

Year:  2009        PMID: 19415010     DOI: 10.1097/MPH.0b013e3181923cc5

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  16 in total

1.  Treatment of Nonmetastatic Unilateral Retinoblastoma in Children.

Authors:  Verónica Pérez; Claudia Sampor; Guadalupe Rey; Andreu Parareda-Salles; Katherine Kopp; Agustín P Dabezies; Gustavo Dufort; Marta Zelter; Juan P López; Marcelo Urbieta; Elisa Alcalde-Ruiz; Jaume Catala-Mora; Mariona Suñol; Diego Ossandon; Adriana C Fandiño; J Oscar Croxatto; María T G de Dávila; Gregory Reaman; Yaddanapudi Ravindranath; Guillermo L Chantada
Journal:  JAMA Ophthalmol       Date:  2018-07-01       Impact factor: 7.389

2.  Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.

Authors:  Nicolas Alessandro Yannuzzi; Jasmine H Francis; Brian P Marr; Irina Belinsky; Ira J Dunkel; Yves Pierre Gobin; David Harold Abramson
Journal:  JAMA Ophthalmol       Date:  2015-09       Impact factor: 7.389

Review 3.  Management of retinoblastoma in children: current status.

Authors:  Guillermo Chantada; Paula Schaiquevich
Journal:  Paediatr Drugs       Date:  2015-06       Impact factor: 3.022

4.  Correlation between conventional MR imaging combined with diffusion-weighted imaging and histopathologic findings in eyes primarily enucleated for advanced retinoblastoma: a retrospective study.

Authors:  Yanfen Cui; Ran Luo; Ruifen Wang; Huanhuan Liu; Caiyuan Zhang; Zhongyang Zhang; Dengbin Wang
Journal:  Eur Radiol       Date:  2017-08-07       Impact factor: 5.315

5.  Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.

Authors:  Jesse L Berry; Kaitlin Kogachi; Hassan A Aziz; Kathleen McGovern; Emily Zolfaghari; A Linn Murphree; Rima Jubran; Jonathan W Kim
Journal:  Pediatr Blood Cancer       Date:  2016-11-05       Impact factor: 3.167

6.  Retinoblastoma major review with updates on Middle East management protocols.

Authors:  Ihab Saad Othman
Journal:  Saudi J Ophthalmol       Date:  2012-04

7.  Use of intra-arterial chemotherapy for retinoblastoma: results of a survey.

Authors:  Nathalia Grigorovski; Evandro Lucena; Clarissa Mattosinho; Andreu Parareda; Sima Ferman; Jaume Catalá; Guillermo Chantada
Journal:  Int J Ophthalmol       Date:  2014-08-18       Impact factor: 1.779

Review 8.  Risk definition and management strategies in retinoblastoma: current perspectives.

Authors:  Fariba Ghassemi; Alireza Khodabande
Journal:  Clin Ophthalmol       Date:  2015-06-08

9.  Optic Nerve Obscuration in Retinoblastoma: A Risk Factor for Optic Nerve Invasion?

Authors:  Jesse L Berry; Emily Zolfaghari; Alexander Chen; A Linn Murphree; Rima Jubran; Jonathan W Kim
Journal:  Ocul Oncol Pathol       Date:  2017-04-07

10.  Comprehensive Somatic Copy Number Analysis Using Aqueous Humor Liquid Biopsy for Retinoblastoma.

Authors:  Mary E Kim; Ashley Polski; Liya Xu; Rishvanth K Prabakar; Chen-Ching Peng; Mark W Reid; Rachana Shah; Peter Kuhn; David Cobrinik; James Hicks; Jesse L Berry
Journal:  Cancers (Basel)       Date:  2021-07-03       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.